메뉴 건너뛰기




Volumn 6, Issue 10, 2006, Pages 2348-2355

Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose peg-interferon and ribavirin

Author keywords

Full dose peg IFN ribavirin; HCV recurrence; Infection; Liver transplantation; Side effects; SVR

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON; RIBAVIRIN; TACROLIMUS;

EID: 33748497126     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01470.x     Document Type: Article
Times cited : (114)

References (52)
  • 1
    • 0036207348 scopus 로고    scopus 로고
    • The association between hepatitis C infection and survival after orthotopic liver transplantation
    • Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122: 889-896.
    • (2002) Gastroenterology , vol.122 , pp. 889-896
    • Forman, L.M.1    Lewis, J.D.2    Berlin, J.A.3    Feldman, H.I.4    Lucey, M.R.5
  • 2
    • 0030907160 scopus 로고    scopus 로고
    • Prospective study of hepatitis C virus infection after orthotopic liver transplantation
    • Barcena R, Del Campo S, Sanromán AL et al. Prospective study of hepatitis C virus infection after orthotopic liver transplantation. Transplant Proc 1997; 29: 515-516.
    • (1997) Transplant Proc , vol.29 , pp. 515-516
    • Barcena, R.1    Del Campo, S.2    Sanromán, A.L.3
  • 3
    • 0034049483 scopus 로고    scopus 로고
    • Prediction of liver allograft fibrosis after transplantation for hepatitis C virus: Persistent elevation of serum transaminase levels versus necroinflammatory activity
    • Pelletier SJ, Iezzoni JC, Crabtree TD, Hahn YS, Sawyer RG, Pruett TL. Prediction of liver allograft fibrosis after transplantation for hepatitis C virus: Persistent elevation of serum transaminase levels versus necroinflammatory activity. Liver Transpl 2000; 6: 44-53.
    • (2000) Liver Transpl , vol.6 , pp. 44-53
    • Pelletier, S.J.1    Iezzoni, J.C.2    Crabtree, T.D.3    Hahn, Y.S.4    Sawyer, R.G.5    Pruett, T.L.6
  • 4
    • 0032899215 scopus 로고    scopus 로고
    • High incidence of allograft cirrhosis in HCV genotype 1b following transplantation: Relationship with rejection episodes
    • Prieto M, Berenguer M, Rayon J et al. High incidence of allograft cirrhosis in HCV genotype 1b following transplantation: Relationship with rejection episodes. Hepatology 1999; 29: 250-256.
    • (1999) Hepatology , vol.29 , pp. 250-256
    • Prieto, M.1    Berenguer, M.2    Rayon, J.3
  • 5
    • 7244247475 scopus 로고    scopus 로고
    • Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
    • Neumann UP, Berg T, Bahra M et al. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. J Hepatol 2004; 41: 830-836.
    • (2004) J Hepatol , vol.41 , pp. 830-836
    • Neumann, U.P.1    Berg, T.2    Bahra, M.3
  • 6
    • 18444415726 scopus 로고    scopus 로고
    • Contribution of donors age to the recent decrease in percents survival among HCV-infected liver transplant recipients
    • Berenguer M, Prieto M, San Juan F et al. Contribution of donors age to the recent decrease in percents survival among HCV-infected liver transplant recipients. Hepatology 2002; 36: 202-210.
    • (2002) Hepatology , vol.36 , pp. 202-210
    • Berenguer, M.1    Prieto, M.2    San Juan, F.3
  • 7
    • 0037080560 scopus 로고    scopus 로고
    • Impact of recurrence of hepatitis C virus infection after liver transplantation on the long term viability of the graft
    • Sanchez Fueyo A, Restrepo JC, Quinto L et al. Impact of recurrence of hepatitis C virus infection after liver transplantation on the long term viability of the graft. Transplantation 2002; 73: 56-63.
    • (2002) Transplantation , vol.73 , pp. 56-63
    • Sanchez Fueyo, A.1    Restrepo, J.C.2    Quinto, L.3
  • 8
    • 0034070192 scopus 로고    scopus 로고
    • HCV-related fibrosis progression following liver transplantation: Increase in recent years
    • Berenguer M, Ferrell L, Watson J et al. HCV-related fibrosis progression following liver transplantation: Increase in recent years. J Hepatol 2000; 32: 673-684.
    • (2000) J Hepatol , vol.32 , pp. 673-684
    • Berenguer, M.1    Ferrell, L.2    Watson, J.3
  • 9
    • 0036073498 scopus 로고    scopus 로고
    • Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C
    • Wali M, Harrison RF, Gow PJ, Mutimer DJ. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 2002; 51: 248-252.
    • (2002) Gut , vol.51 , pp. 248-252
    • Wali, M.1    Harrison, R.F.2    Gow, P.J.3    Mutimer, D.J.4
  • 10
    • 0030933395 scopus 로고    scopus 로고
    • Natural history of liver fibrosis progression in patients with chronic hepatitis C
    • Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-832.
    • (1997) Lancet , vol.349 , pp. 825-832
    • Poynard, T.1    Bedossa, P.2    Opolon, P.3
  • 11
    • 0029088814 scopus 로고
    • An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejection
    • Feray C, Samuel D, Gigou M et al. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejection. Hepatology 1995; 22: 1084-1089.
    • (1995) Hepatology , vol.22 , pp. 1084-1089
    • Feray, C.1    Samuel, D.2    Gigou, M.3
  • 12
    • 0037371521 scopus 로고    scopus 로고
    • Interferon alfa 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomised study
    • Samuel D, Bizollon T, Feray C et al. Interferon alfa 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomised study. Gastroenterology 2003; 124: 642-650.
    • (2003) Gastroenterology , vol.124 , pp. 642-650
    • Samuel, D.1    Bizollon, T.2    Feray, C.3
  • 13
    • 0029039362 scopus 로고
    • Histological grading and staging of chronic hepatitis
    • Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699.
    • (1995) J Hepatol , vol.22 , pp. 696-699
    • Ishak, K.1    Baptista, A.2    Bianchi, L.3
  • 14
  • 15
    • 20544436473 scopus 로고    scopus 로고
    • Partial esplenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirin
    • Barcena R, Gil-Grande L, Moreno J et al. Partial esplenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirin. Transplantation 2005; 79: 1634-1635.
    • (2005) Transplantation , vol.79 , pp. 1634-1635
    • Barcena, R.1    Gil-Grande, L.2    Moreno, J.3
  • 16
    • 0037179698 scopus 로고    scopus 로고
    • Peginterferon alfa 2a plus ribavirin for chronic hepatitis C virus infection
    • Fried MW, Shiffman ML, Reddy KR et al. Peginterferon alfa 2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-982.
    • (2002) N Engl J Med , vol.347 , pp. 975-982
    • Fried, M.W.1    Shiffman, M.L.2    Reddy, K.R.3
  • 17
    • 0042442463 scopus 로고    scopus 로고
    • Hematologic disorders associated with hepatitis C virus infection and their management
    • Dieterich DT, Spivak JL. Hematologic disorders associated with hepatitis C virus infection and their management. Clin Infect Dis 2003; 37: 533-541.
    • (2003) Clin Infect Dis , vol.37 , pp. 533-541
    • Dieterich, D.T.1    Spivak, J.L.2
  • 18
    • 10744233319 scopus 로고    scopus 로고
    • Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: An open-label series
    • Rodriguez-Luna H, Khatib A, Sharma P et al. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: An open-label series. Transplantation 2004; 77: 190-194.
    • (2004) Transplantation , vol.77 , pp. 190-194
    • Rodriguez-Luna, H.1    Khatib, A.2    Sharma, P.3
  • 19
    • 1642293907 scopus 로고    scopus 로고
    • Treatment of recurrent hepatitis C after liver transplantation: A pilot study of peginterferon alfa-2b and ribavirin combination
    • Dumortier J, Scoazec JY, Chevallier P, Boillot O. Treatment of recurrent hepatitis C after liver transplantation: A pilot study of peginterferon alfa-2b and ribavirin combination. J Hepatol 2004; 40: 669-674.
    • (2004) J Hepatol , vol.40 , pp. 669-674
    • Dumortier, J.1    Scoazec, J.Y.2    Chevallier, P.3    Boillot, O.4
  • 20
    • 8644285360 scopus 로고    scopus 로고
    • Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy
    • Neff GW, Montalbano M, O'Brien CB et al. Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy. Transplantation 2004; 78: 1303-1307.
    • (2004) Transplantation , vol.78 , pp. 1303-1307
    • Neff, G.W.1    Montalbano, M.2    O'Brien, C.B.3
  • 21
    • 19944386924 scopus 로고    scopus 로고
    • Pegylated versus standard interferon-alfa in antiviral regimens for post-transplant recurrent hepatitis C: Comparison of tolerability and efficacy
    • Toniutto P, Fabris C, Fumo E et al. Pegylated versus standard interferon-alfa in antiviral regimens for post-transplant recurrent hepatitis C: Comparison of tolerability and efficacy. J Gastroenterol Hepatol 2005; 20: 577-582.
    • (2005) J Gastroenterol Hepatol , vol.20 , pp. 577-582
    • Toniutto, P.1    Fabris, C.2    Fumo, E.3
  • 22
    • 11844249361 scopus 로고    scopus 로고
    • Applicability tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation
    • Shergill AK, Khalili M, Straley S et al. Applicability tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. Am J Transplant 2005; 5: 118-124.
    • (2005) Am J Transplant , vol.5 , pp. 118-124
    • Shergill, A.K.1    Khalili, M.2    Straley, S.3
  • 23
    • 22444439336 scopus 로고    scopus 로고
    • Pegylated interferon alpha 2b and ribavirin for recurrent hepatitis C after liver transplantation: From a Canadian experience to recommendations for therapy
    • Babatin M, Schindel L, Burak KW. Pegylated interferon alpha 2b and ribavirin for recurrent hepatitis C after liver transplantation: From a Canadian experience to recommendations for therapy. Can J Gastroenterol 2005; 19: 359-365.
    • (2005) Can J Gastroenterol , vol.19 , pp. 359-365
    • Babatin, M.1    Schindel, L.2    Burak, K.W.3
  • 24
    • 33646815725 scopus 로고    scopus 로고
    • Pegylated interferon plus ribavirin for recurrent hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen
    • Biselli M, Andreone P, Gramenzi A et al. Pegylated interferon plus ribavirin for recurrent hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen. Dig Liv Dis 2006; 38: 27-32.
    • (2006) Dig Liv Dis , vol.38 , pp. 27-32
    • Biselli, M.1    Andreone, P.2    Gramenzi, A.3
  • 25
    • 29544446176 scopus 로고    scopus 로고
    • Pegylated interferon and ribavirin for the recurrence of chronic hepatitis C genotype 1 in transplant patients
    • Oton E, Barcena R, Garcia-Garzon S et al. Pegylated interferon and ribavirin for the recurrence of chronic hepatitis C genotype 1 in transplant patients. Transplant Proc 2005; 37: 3963-3964.
    • (2005) Transplant Proc , vol.37 , pp. 3963-3964
    • Oton, E.1    Barcena, R.2    Garcia-Garzon, S.3
  • 26
    • 17344367725 scopus 로고    scopus 로고
    • The efficacy of prophylactic interferon alfa 2b in preventing recurrent hepatitis C after liver transplantation
    • Sheiner PA, Boros P, Klion FM et al. The efficacy of prophylactic interferon alfa 2b in preventing recurrent hepatitis C after liver transplantation. Hepatology 1998; 28: 831-838.
    • (1998) Hepatology , vol.28 , pp. 831-838
    • Sheiner, P.A.1    Boros, P.2    Klion, F.M.3
  • 27
    • 0031887327 scopus 로고    scopus 로고
    • Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant patients: A prospective randomized controlled trial
    • Singh N, Gayowski T, Wannstedt CF et al. Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant patients: a prospective randomized controlled trial. Transplantation 1998; 65: 82-86.
    • (1998) Transplantation , vol.65 , pp. 82-86
    • Singh, N.1    Gayowski, T.2    Wannstedt, C.F.3
  • 28
    • 19944430229 scopus 로고    scopus 로고
    • Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials
    • Chalasani N, Manzarbeitia C, Ferenci P et al. Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials. Hepatology 2005; 41: 289-298.
    • (2005) Hepatology , vol.41 , pp. 289-298
    • Chalasani, N.1    Manzarbeitia, C.2    Ferenci, P.3
  • 29
    • 20444377637 scopus 로고    scopus 로고
    • Combined treatment with pegylated interferon (alfa-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation
    • Castells L, Vargas V, Allende H et al. Combined treatment with pegylated interferon (alfa-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation. J Hepatol 2005; 43: 53-59.
    • (2005) J Hepatol , vol.43 , pp. 53-59
    • Castells, L.1    Vargas, V.2    Allende, H.3
  • 30
    • 1642565346 scopus 로고    scopus 로고
    • Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C
    • Ross AS, Bhan AK, Pascual M, Thiim M, Cosimi AB, Chung RT. Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C. Clin Transplant 2004; 18: 166-173.
    • (2004) Clin Transplant , vol.18 , pp. 166-173
    • Ross, A.S.1    Bhan, A.K.2    Pascual, M.3    Thiim, M.4    Cosimi, A.B.5    Chung, R.T.6
  • 31
    • 26244443798 scopus 로고    scopus 로고
    • HCV clearance and treatment outcome in genotype 1 HCV-monoinfected and liver transplanted patients on peg-IFN-α-2b/ribavirin
    • Moreno A, Barcena R, Garcia-Garzon S et al. HCV clearance and treatment outcome in genotype 1 HCV-monoinfected and liver transplanted patients on peg-IFN-α-2b/ribavirin. J Hepatol 2005; 43: 783-790.
    • (2005) J Hepatol , vol.43 , pp. 783-790
    • Moreno, A.1    Barcena, R.2    Garcia-Garzon, S.3
  • 32
    • 3242780201 scopus 로고    scopus 로고
    • Outcomes of acute rejection after interferon therapy in liver transplant recipients
    • Saab S, Kalmaz D, Gajjar NA et al. Outcomes of acute rejection after interferon therapy in liver transplant recipients. Liver Transpl 2004; 10: 859-867.
    • (2004) Liver Transpl , vol.10 , pp. 859-867
    • Saab, S.1    Kalmaz, D.2    Gajjar, N.A.3
  • 34
    • 0033564449 scopus 로고    scopus 로고
    • Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: Coincidence or true side effect?
    • Ravandi-Kashani F, Cortes J, Talpaz M, Kantarjian HM. Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: Coincidence or true side effect?. Cancer 1999; 85: 2583-2588.
    • (1999) Cancer , vol.85 , pp. 2583-2588
    • Ravandi-Kashani, F.1    Cortes, J.2    Talpaz, M.3    Kantarjian, H.M.4
  • 36
    • 4644282559 scopus 로고    scopus 로고
    • Hepatic artery stenosis in liver transplanted patients treated with pegylated interferon alpha-2b and ribavirin
    • Biselli M, Lorenzini S, Gramenzi A et al. Hepatic artery stenosis in liver transplanted patients treated with pegylated interferon alpha-2b and ribavirin. Transplantation 2004; 78: 953.
    • (2004) Transplantation , vol.78 , pp. 953
    • Biselli, M.1    Lorenzini, S.2    Gramenzi, A.3
  • 37
    • 0023854279 scopus 로고
    • Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alfa treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections
    • Kovarik J, Mayer G, Pohanka E et al. Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alfa treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections. Transplantation 1988; 45: 402-405.
    • (1988) Transplantation , vol.45 , pp. 402-405
    • Kovarik, J.1    Mayer, G.2    Pohanka, E.3
  • 38
    • 0021339127 scopus 로고
    • Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients
    • Kramer P, ten Kate FW, Bijnen AB, Jeekel J, Weimar W. Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients. Lancet 1984; 989-990.
    • (1984) Lancet , pp. 989-990
    • Kramer, P.1    Ten Kate, F.W.2    Bijnen, A.B.3    Jeekel, J.4    Weimar, W.5
  • 39
    • 0030795196 scopus 로고    scopus 로고
    • Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation
    • Bizollon T, Palazzo U, Ducerf C et al. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology 1997; 26: 500-504.
    • (1997) Hepatology , vol.26 , pp. 500-504
    • Bizollon, T.1    Palazzo, U.2    Ducerf, C.3
  • 40
    • 3242772980 scopus 로고    scopus 로고
    • Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis following liver transplantation
    • Stravitz RT, Shiffman ML, Sanyal AJ et al. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis following liver transplantation. Liver Transpl 2004; 10: 850-858.
    • (2004) Liver Transpl , vol.10 , pp. 850-858
    • Stravitz, R.T.1    Shiffman, M.L.2    Sanyal, A.J.3
  • 41
    • 22844435314 scopus 로고    scopus 로고
    • Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C
    • Bizollon T, Pradat P, Mabrut JY et al. Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C. Am J Transpl 2005; 5: 1909-1913.
    • (2005) Am J Transpl , vol.5 , pp. 1909-1913
    • Bizollon, T.1    Pradat, P.2    Mabrut, J.Y.3
  • 42
    • 0036850944 scopus 로고    scopus 로고
    • Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C
    • Firpi RJ, Abdelmalek MF, Soldevila-Pico C et al. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C. Liver Transpl 2002; 8: 1000-1006.
    • (2002) Liver Transpl , vol.8 , pp. 1000-1006
    • Firpi, R.J.1    Abdelmalek, M.F.2    Soldevila-Pico, C.3
  • 43
    • 0037302607 scopus 로고    scopus 로고
    • Long-term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence
    • Bizollon T, Ahmed SNS, Radenne S et al. Long-term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence. Gut 2003; 52: 283-287.
    • (2003) Gut , vol.52 , pp. 283-287
    • Bizollon, T.1    Ahmed, S.N.S.2    Radenne, S.3
  • 44
    • 24144468662 scopus 로고    scopus 로고
    • Suppression of hepatitis C virus replication by cyclosporin A is mediated by blockade of cyclophilins
    • Nakagawa M, Sakamoto N, Tanabe Y et al. Suppression of hepatitis C virus replication by cyclosporin A is mediated by blockade of cyclophilins. Gastroenterology 2005; 129: 1031-1041.
    • (2005) Gastroenterology , vol.129 , pp. 1031-1041
    • Nakagawa, M.1    Sakamoto, N.2    Tanabe, Y.3
  • 45
    • 0142182744 scopus 로고    scopus 로고
    • Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes
    • Watashi K, Hijikata M, Hosaka M, Yamaji M, Shimotohno K. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology 2003; 38: 1282-1288.
    • (2003) Hepatology , vol.38 , pp. 1282-1288
    • Watashi, K.1    Hijikata, M.2    Hosaka, M.3    Yamaji, M.4    Shimotohno, K.5
  • 46
    • 33645106470 scopus 로고    scopus 로고
    • Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation
    • Firpi RJ, Zhu H, Morelli G et al. Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation. Liver Transpl 2006; 12: 51-57.
    • (2006) Liver Transpl , vol.12 , pp. 51-57
    • Firpi, R.J.1    Zhu, H.2    Morelli, G.3
  • 47
    • 0035660141 scopus 로고    scopus 로고
    • Histological recurrence and progression of hepatitis C after orthotopic liver transplantation: Influence of immunosuppressive regimens
    • Hunt J, Gordon FD, Lewis WD et al. Histological recurrence and progression of hepatitis C after orthotopic liver transplantation: Influence of immunosuppressive regimens. Liver Transpl 2001; 7: 1056-1063.
    • (2001) Liver Transpl , vol.7 , pp. 1056-1063
    • Hunt, J.1    Gordon, F.D.2    Lewis, W.D.3
  • 48
    • 0035881343 scopus 로고    scopus 로고
    • The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis
    • Papatheodoridis GV, Davies S, Dhillon AP et al. The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis. Transplantation 2001; 72: 412-418.
    • (2001) Transplantation , vol.72 , pp. 412-418
    • Papatheodoridis, G.V.1    Davies, S.2    Dhillon, A.P.3
  • 49
    • 0033812220 scopus 로고    scopus 로고
    • Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patients
    • Testa G, Crippin JS, Netto GJ et al. Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patients. Liver Transpl 2000; 6: 553-561.
    • (2000) Liver Transpl , vol.6 , pp. 553-561
    • Testa, G.1    Crippin, J.S.2    Netto, G.J.3
  • 50
    • 10744221228 scopus 로고    scopus 로고
    • Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation
    • Chopra KB, Demetris AJ, Blakolmer K et al. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation. Transplantation 2003; 76: 1487-1491.
    • (2003) Transplantation , vol.76 , pp. 1487-1491
    • Chopra, K.B.1    Demetris, A.J.2    Blakolmer, K.3
  • 51
    • 20244366386 scopus 로고    scopus 로고
    • Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation
    • Samonakis DN, Triantos CK, Thalheimer U et al. Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation. Liver Transpl 2005; 11: 386-395.
    • (2005) Liver Transpl , vol.11 , pp. 386-395
    • Samonakis, D.N.1    Triantos, C.K.2    Thalheimer, U.3
  • 52
    • 0742321955 scopus 로고    scopus 로고
    • Long-term outcome of liver transplants for chronic hepatitis C: A 10-year follow-up
    • Neumann UP, Berg T, Bahra M et al. Long-term outcome of liver transplants for chronic hepatitis C: A 10-year follow-up. Transplantation 2004; 77: 226-231.
    • (2004) Transplantation , vol.77 , pp. 226-231
    • Neumann, U.P.1    Berg, T.2    Bahra, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.